Patrick Ryan
Patrick Ryan
Janssen Research and Development
Verified email at cornell.edu
TitleCited byYear
Novel data‐mining methodologies for adverse drug event discovery and analysis
R Harpaz, W DuMouchel, NH Shah, D Madigan, P Ryan, C Friedman
Clinical Pharmacology & Therapeutics 91 (6), 1010-1021, 2012
2882012
Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership
PE Stang, PB Ryan, JA Racoosin, JM Overhage, AG Hartzema, C Reich, ...
Annals of internal medicine 153 (9), 600-606, 2010
2882010
Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers
G Hripcsak, JD Duke, NH Shah, CG Reich, V Huser, MJ Schuemie, ...
Studies in health technology and informatics 216, 574, 2015
2822015
Validation of a common data model for active safety surveillance research
JM Overhage, PB Ryan, CG Reich, AG Hartzema, PE Stang
Journal of the American Medical Informatics Association 19 (1), 54-60, 2012
1912012
Performance of pharmacovigilance signal‐detection algorithms for the FDA adverse event reporting system
R Harpaz, W DuMouchel, P LePendu, A Bauer‐Mehren, P Ryan, ...
Clinical Pharmacology & Therapeutics 93 (6), 539-546, 2013
1692013
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership
PB Ryan, D Madigan, PE Stang, J Marc Overhage, JA Racoosin, ...
Statistics in medicine 31 (30), 4401-4415, 2012
1522012
Evaluating the impact of database heterogeneity on observational study results
D Madigan, PB Ryan, M Schuemie, PE Stang, JM Overhage, ...
American journal of epidemiology 178 (4), 645-651, 2013
1232013
Characterizing treatment pathways at scale using the OHDSI network
G Hripcsak, PB Ryan, JD Duke, NH Shah, RW Park, V Huser, MA Suchard, ...
Proceedings of the National Academy of Sciences 113 (27), 7329-7336, 2016
1172016
Control of reproductive floral organ identity specification in Arabidopsis by the C function regulator AGAMOUS
DS Ó’Maoiléidigh, SE Wuest, L Rae, A Raganelli, PT Ryan, ...
The Plant Cell 25 (7), 2482-2503, 2013
1092013
Interpreting observational studies: why empirical calibration is needed to correct p‐values
MJ Schuemie, PB Ryan, W DuMouchel, MA Suchard, D Madigan
Statistics in medicine 33 (2), 209-218, 2014
942014
Defining a reference set to support methodological research in drug safety
PB Ryan, MJ Schuemie, E Welebob, J Duke, S Valentine, AG Hartzema
Drug safety 36 (1), 33-47, 2013
882013
A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data
MG Kahn, TJ Callahan, J Barnard, AE Bauck, J Brown, BN Davidson, ...
Egems 4 (1), 2016
842016
Disproportionality methods for pharmacovigilance in longitudinal observational databases
I Zorych, D Madigan, P Ryan, A Bate
Statistical methods in medical research 22 (1), 39-56, 2013
842013
Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases
SJ Reisinger, PB Ryan, DJ O'Hara, GE Powell, JL Painter, EN Pattishall, ...
Journal of the American Medical Informatics Association 17 (6), 652-662, 2010
712010
A comparison of the empirical performance of methods for a risk identification system
PB Ryan, PE Stang, JM Overhage, MA Suchard, AG Hartzema, ...
Drug safety 36 (1), 143-158, 2013
612013
A systematic statistical approach to evaluating evidence from observational studies
D Madigan, PE Stang, JA Berlin, M Schuemie, JM Overhage, MA Suchard, ...
Annual Review of Statistics and Its Application 1, 11-39, 2014
602014
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases
EA Voss, R Makadia, A Matcho, Q Ma, C Knoll, M Schuemie, FJ DeFalco, ...
Journal of the American Medical Informatics Association 22 (3), 553-564, 2015
572015
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 …
PB Ryan, JB Buse, MJ Schuemie, F DeFalco, Z Yuan, PE Stang, JA Berlin, ...
Diabetes, Obesity and Metabolism 20 (11), 2585-2597, 2018
562018
Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: a retrospective cohort study
Z Yuan, FJ DeFalco, PB Ryan, MJ Schuemie, PE Stang, JA Berlin, ...
Diabetes, Obesity and Metabolism 20 (3), 582-589, 2018
542018
Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases
C Reich, PB Ryan, PE Stang, M Rocca
Journal of biomedical informatics 45 (4), 689-696, 2012
532012
The system can't perform the operation now. Try again later.
Articles 1–20